Previous studies have shown that knockdown of the ABCB1 gene can re-sensitize and increase the intracellular accumulation of chemotherapeutics in drug-resistant ovarian cancer cells, making it a suitable target for treatment [22,23]. The gene discussed is ABCB1; the disease is ovarian carcinoma.